Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Cebpz (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CEBPZ mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | affects binding | EXP | | 6480464 | Dinitrochlorobenzene binds to CEBPZ protein | CTD | PMID:32991956 | 17alpha-ethynylestradiol | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CEBPZ mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Cebpz (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA | CTD | PMID:17942748 | 17beta-estradiol | affects expression | ISO | Cebpz (Mus musculus) | 6480464 | Estradiol affects the expression of CEBPZ mRNA | CTD | PMID:15598610 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CEBPZ mRNA | CTD | PMID:31614463 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA | CTD | PMID:20823114 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cebpz (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPZ mRNA | CTD | PMID:17942748 and PMID:19684285 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPZ mRNA | CTD | PMID:19684285 | 2,4-dinitrotoluene | affects expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of CEBPZ mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of CEBPZ mRNA | CTD | PMID:21346803 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of CEBPZ mRNA | CTD | PMID:18648102 | aflatoxin M1 | decreases expression | EXP | | 6480464 | Aflatoxin M1 results in decreased expression of CEBPZ mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CEBPZ mRNA | CTD | PMID:16054129 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CEBPZ mRNA | CTD | PMID:15894607 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of CEBPZ mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CEBPZ mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CEBPZ mRNA | CTD | PMID:20458559 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Cebpz (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of and results in increased activity of CEBPZ protein | CTD | PMID:35842051 | bisphenol A | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CEBPZ mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CEBPZ protein | CTD | PMID:37567409 | bucladesine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA | CTD | PMID:20823114 | cadmium dichloride | decreases methylation | ISO | Cebpz (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of CEBPZ promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of CEBPZ mRNA | CTD | PMID:18974090 | camptothecin | decreases expression | EXP | | 6480464 | Camptothecin results in decreased expression of CEBPZ mRNA | CTD | PMID:17374387 | chlorpyrifos | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CEBPZ mRNA | CTD | PMID:37019170 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CEBPZ mRNA | CTD | PMID:20106945 and PMID:25562108 | cyproconazole | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | cyproconazole results in decreased expression of CEBPZ mRNA | CTD | PMID:22334560 | daunorubicin | decreases expression | EXP | | 6480464 | Daunorubicin results in decreased expression of CEBPZ mRNA | CTD | PMID:17374387 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CEBPZ mRNA | CTD | PMID:20458559 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CEBPZ mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA | CTD | PMID:27188386 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of CEBPZ mRNA | CTD | PMID:26272509 | epoxiconazole | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CEBPZ mRNA | CTD | PMID:22334560 | etoposide | decreases expression | EXP | | 6480464 | Etoposide results in decreased expression of CEBPZ mRNA | CTD | PMID:17374387 | fluoranthene | multiple interactions | ISO | Cebpz (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPZ mRNA | CTD | PMID:28329830 | flutamide | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of CEBPZ mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CEBPZ mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of CEBPZ protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CEBPZ mRNA | CTD | PMID:22061828 and PMID:33387578 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of CEBPZ protein | CTD | PMID:32959892 | medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA | CTD | PMID:20823114 | N-nitrosodiethylamine | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of CEBPZ mRNA | CTD | PMID:19041683 | ochratoxin A | decreases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased expression of CEBPZ mRNA | CTD | PMID:18417182 | pirinixic acid | increases expression | ISO | Cebpz (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CEBPZ mRNA | CTD | PMID:23811191 | propiconazole | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | propiconazole results in decreased expression of CEBPZ mRNA | CTD | PMID:22334560 | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [CEBPZ binds to COL1A1 promoter] | CTD | PMID:16575855 | sodium dichromate | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | sodium bichromate results in increased expression of CEBPZ mRNA | CTD | PMID:25993096 | Soman | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Soman results in increased expression of CEBPZ mRNA | CTD | PMID:19281266 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of CEBPZ mRNA | CTD | PMID:31758290 | tetrachloromethane | multiple interactions | ISO | Cebpz (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of CEBPZ mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CEBPZ mRNA | CTD | PMID:23411599 and PMID:34492290 | tungsten | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | Tungsten results in decreased expression of CEBPZ mRNA | CTD | PMID:30912803 | valproic acid | decreases expression | ISO | Cebpz (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of CEBPZ mRNA | CTD | PMID:21427059 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CEBPZ mRNA | CTD | PMID:23179753 and PMID:27188386 | vinclozolin | increases expression | ISO | Cebpz (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of CEBPZ mRNA | CTD | PMID:23555832 | |